Blog
AI-Assisted Biopsy Diagnosis, Historical Misdiagnosis in Norway, and Screen-Detected Celiac Outcomes | The Gluten-Free Brief – August 21, 2026
A Cleveland Clinic AI model reaches 97% accuracy distinguishing celiac from normal biopsies, while a Norwegian study finds evidence of historical misdiagnosis. Plus long-term outcomes, COVID-19 risk and recalls.
Spain Celiac Subsidy, Sydney Airport Labeling, and Congress Bills | The Gluten-Free Brief – August 7, 2026
Spain funds gluten-free diets, Sydney Airport’s labeling faces scrutiny, and four bills advance in Congress. Plus a drug acquisition and product recalls.
Tunisia’s Gluten-Free Funding Boost, UK Diagnosis Update, and a New Global “May Contain” Standard | The Gluten-Free Brief – July 21, 2026
Tunisia funds gluten-free diets, Codex sets a global “may contain” gluten standard, and the UK updates celiac diagnosis guidance. Plus recalls.
Stroke Patient Repeatedly Served Gluten, New Celiac Disease Research, and UK & France Recalls | The Gluten-Free Brief – July 7, 2026
The latest gluten-free news from around the world: a New Zealand hospital case, new celiac disease research from Norway, advocacy stories from Malta and Spain, and recent gluten-related recalls in the UK and France.
Gluten and faith: an unresolved conflict
How Catholic, Orthodox, and Jewish traditions navigate gluten-free needs in communion, matzo, and ritual food — and where the conflicts remain unresolved.
FDA Gluten Review, Virginia Allergy Labels, and New Celiac Research | The Gluten-Free Brief
June’s gluten-free news: FDA’s labeling review, Virginia’s takeout law, beer testing gaps, a probiotic yeast study, and recalls in three countries.
Have questions or not sure where to start?
Contact us to speak with a representative or receive a no-obligation quote. Our staff is available anytime to answer questions and help navigate the decisions toward achieving gluten-free certification for your company.
